Vinpai: Camlin Fine Sciences Holds 95.41% of Capital After Its Simplified Tender Offer, No Mandatory Squeeze-Out
Camlin Fine Sciences completed its simplified public tender offer on Vinpai on July 6, 2026, increasing its stake to 95.41% of the capital, without initiating a mandatory squeeze-out procedure.
Completion of the Simplified Tender Offer and Increased Stake
Camlin Fine Sciences Limited (an Indian group active in preservation solutions for flavor and wellness ingredients) announces the completion of the simplified public tender offer (OPAS) for the remaining shares of Vinpai, constituting its capital. Following the close of the OPAS on July 6, 2026, Camlin Fine Sciences now holds a total of 4,351,894 shares and 4,325,158 theoretical voting rights, representing 95.41% of the share capital and 91.46% of the theoretical voting rights.
No Request for Mandatory Squeeze-Out
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Camlin Fine Sciences confirms that it will not request the implementation of a mandatory squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.
Related
SectorAgroalimentaire et boissons›Industrie alimentaire
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3,8 millions d'euros
Quarterly revenue: 3,8 millions d'euros
EBITDA: -1,2 millions d'euros
Net income: -1,7 millions d'euros
Guidance from the release
« Vinpai entend reprendre sa dynamique de croissance historique » mais sans objectifs chiffrés explicites ; dépendance au soutien de la maison mère
Risks mentioned
Arrêt soudain des expéditions en Algérie au T2 2026 impactant significativement les résultats financiers
Forte dépendance aux clients du Moyen-Orient et Afrique (représentaient plus de 50% du CA jusqu'en 2025)
Pression sur la marge brute due à un mix produit défavorable
Opportunities identified
Utilisation de l'organisation de vente de CAMLIN Fine Sciences Limited pour augmenter significativement les ventes
Carnet de commandes de 2,8 M€ (stable vs 2,7 M€ à juin 2025) offrant une base de relance
Croissance significative en Europe (hors France) : +233% (€945k vs €283k en 2025)
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
